146 related articles for article (PubMed ID: 9222640)
1. Antioxidant treatment of experimental diabetic retinopathy in rats with nicanartine.
Hammes HP; Bartmann A; Engel L; Wülfroth P
Diabetologia; 1997 Jun; 40(6):629-34. PubMed ID: 9222640
[TBL] [Abstract][Full Text] [Related]
2. Acceleration of experimental diabetic retinopathy in the rat by omega-3 fatty acids.
Hammes HP; Weiss A; Führer D; Krämer HJ; Papavassilis C; Grimminger F
Diabetologia; 1996 Mar; 39(3):251-5. PubMed ID: 8721768
[TBL] [Abstract][Full Text] [Related]
3. Aminoguanidine inhibits the development of accelerated diabetic retinopathy in the spontaneous hypertensive rat.
Hammes HP; Brownlee M; Edelstein D; Saleck M; Martin S; Federlin K
Diabetologia; 1994 Jan; 37(1):32-5. PubMed ID: 8150227
[TBL] [Abstract][Full Text] [Related]
4. Oral carnosine supplementation prevents vascular damage in experimental diabetic retinopathy.
Pfister F; Riedl E; Wang Q; vom Hagen F; Deinzer M; Harmsen MC; Molema G; Yard B; Feng Y; Hammes HP
Cell Physiol Biochem; 2011; 28(1):125-36. PubMed ID: 21865855
[TBL] [Abstract][Full Text] [Related]
5. Aminoguanidine does not inhibit the initial phase of experimental diabetic retinopathy in rats.
Hammes HP; Ali SS; Uhlmann M; Weiss A; Federlin K; Geisen K; Brownlee M
Diabetologia; 1995 Mar; 38(3):269-73. PubMed ID: 7758871
[TBL] [Abstract][Full Text] [Related]
6. Effect of R-(+)-alpha-lipoic acid on experimental diabetic retinopathy.
Lin J; Bierhaus A; Bugert P; Dietrich N; Feng Y; Vom Hagen F; Nawroth P; Brownlee M; Hammes HP
Diabetologia; 2006 May; 49(5):1089-96. PubMed ID: 16520919
[TBL] [Abstract][Full Text] [Related]
7. The relationship of glycaemic level to advanced glycation end-product (AGE) accumulation and retinal pathology in the spontaneous diabetic hamster.
Hammes HP; Wellensiek B; Klöting I; Sickel E; Bretzel RG; Brownlee M
Diabetologia; 1998 Feb; 41(2):165-70. PubMed ID: 9498649
[TBL] [Abstract][Full Text] [Related]
8. Low-dose erythropoietin inhibits oxidative stress and early vascular changes in the experimental diabetic retina.
Wang Q; Pfister F; Dorn-Beineke A; vom Hagen F; Lin J; Feng Y; Hammes HP
Diabetologia; 2010 Jun; 53(6):1227-38. PubMed ID: 20339831
[TBL] [Abstract][Full Text] [Related]
9. Secondary intervention with aminoguanidine retards the progression of diabetic retinopathy in the rat model.
Hammes HP; Strödter D; Weiss A; Bretzel RG; Federlin K; Brownlee M
Diabetologia; 1995 Jun; 38(6):656-60. PubMed ID: 7672485
[TBL] [Abstract][Full Text] [Related]
10. Methylglyoxal induces retinopathy-type lesions in the absence of hyperglycemia: studies in a rat model.
Schlotterer A; Kolibabka M; Lin J; Acunman K; Dietrich N; Sticht C; Fleming T; Nawroth P; Hammes HP
FASEB J; 2019 Mar; 33(3):4141-4153. PubMed ID: 30485119
[TBL] [Abstract][Full Text] [Related]
11. Aminoguanidine treatment inhibits the development of experimental diabetic retinopathy.
Hammes HP; Martin S; Federlin K; Geisen K; Brownlee M
Proc Natl Acad Sci U S A; 1991 Dec; 88(24):11555-8. PubMed ID: 1763069
[TBL] [Abstract][Full Text] [Related]
12. Retinopathy is reduced during experimental diabetes in a mouse model of outer retinal degeneration.
de Gooyer TE; Stevenson KA; Humphries P; Simpson DA; Gardiner TA; Stitt AW
Invest Ophthalmol Vis Sci; 2006 Dec; 47(12):5561-8. PubMed ID: 17122149
[TBL] [Abstract][Full Text] [Related]
13. Application of isoproterenol inhibits diabetic-like changes in the rat retina.
Jiang Y; Walker RJ; Kern TS; Steinle JJ
Exp Eye Res; 2010 Aug; 91(2):171-9. PubMed ID: 20493839
[TBL] [Abstract][Full Text] [Related]
14. Treatment with hydrogen sulfide alleviates streptozotocin-induced diabetic retinopathy in rats.
Si YF; Wang J; Guan J; Zhou L; Sheng Y; Zhao J
Br J Pharmacol; 2013 Jun; 169(3):619-31. PubMed ID: 23488985
[TBL] [Abstract][Full Text] [Related]
15. Abnormalities of retinal metabolism in diabetes and experimental galactosemia. VII. Effect of long-term administration of antioxidants on the development of retinopathy.
Kowluru RA; Tang J; Kern TS
Diabetes; 2001 Aug; 50(8):1938-42. PubMed ID: 11473058
[TBL] [Abstract][Full Text] [Related]
16. Antioxidants and an inhibitor of advanced glycation ameliorate death of retinal microvascular cells in diabetic retinopathy.
Yatoh S; Mizutani M; Yokoo T; Kozawa T; Sone H; Toyoshima H; Suzuki S; Shimano H; Kawakami Y; Okuda Y; Yamada N
Diabetes Metab Res Rev; 2006; 22(1):38-45. PubMed ID: 15892182
[TBL] [Abstract][Full Text] [Related]
17. Calcium dobesilate attenuates vascular injury and the progression of diabetic retinopathy in streptozotocin-induced diabetic rats.
Padilla E; Ganado P; Sanz M; Zeini M; Ruiz E; Triviño A; Ramírez AI; Salazar JJ; Ramírez JM; Rojas B; Hoz Rd; Tejerina T
Diabetes Metab Res Rev; 2005; 21(2):132-42. PubMed ID: 15386814
[TBL] [Abstract][Full Text] [Related]
18. Hesperidin prevents retinal and plasma abnormalities in streptozotocin-induced diabetic rats.
Shi X; Liao S; Mi H; Guo C; Qi D; Li F; Zhang C; Yang Z
Molecules; 2012 Nov; 17(11):12868-81. PubMed ID: 23117428
[TBL] [Abstract][Full Text] [Related]
19. Dietary myo-inositol supplementation does not prevent retinal and glomerular vascular structural changes in chronically diabetic rats.
Tilton RG; Faller AM; LaRose LS; Burgan J; Williamson JR
J Diabetes Complications; 1993; 7(3):188-98. PubMed ID: 8343613
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of retinopathy and retinal metabolic abnormalities in diabetic rats with AREDS-based micronutrients.
Kowluru RA; Kanwar M; Chan PS; Zhang JP
Arch Ophthalmol; 2008 Sep; 126(9):1266-72. PubMed ID: 18779489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
